Belarus first country after Russia to start Sputnik-V vaccination

Belarus has become the first country after Russia to begin vaccination of people with Sputnik-V against Covid-19

Coronavirus, vaccine, covid, drugs, clinical trials
Representational image.
ANI Asia
2 min read Last Updated : Dec 29 2020 | 1:44 PM IST

Belarus has become the first country after Russia to begin vaccination of people with Sputnik-V against Covid-19, Russian Direct Investment Fund (RDIF) said on Tuesday.

"Belarus becomes the first country in the world after Russia to start vaccination of its people against COVID-19 with #SputnikV vaccine," a tweet from the official handle of Sputnik-V stated.

The Sputnik-V vaccine has been developed and produced by the Gamaleya National Research Institute of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation.

"We can officially confirm that according to the available data the vaccine is safe and effective, no serious or unexpected side effects have been revealed," Belarusian Healthcare Minister Dmitry Pinevich, was quoted by Belarus media earlier this month.

In a global race to beat Covid-19, scores of vaccines are being developed and a handful is in the final stages of testing, like Sputnik, Pfizer and Oxford.

On Monday, the Serum Institute of India's chief executive Adar Poonawalla announced that the rollout of the Oxford University-AstraZeneca vaccine is expected in January.

Other than Belarus, India too will be producing 300 million doses of the Russian Sputnik V vaccine.

The efficacy of the Sputnik V vaccine has been claimed to be 91.4 per cent.

Belarus on Monday had reported 1,814 new COVID-19 cases that took its total to 188, 588.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :BelarusRussiaCoronavirus Vaccine

First Published: Dec 29 2020 | 1:39 PM IST

Next Story